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Rats subjected to diverse hypertension-inducing procedures develop an abnormal sodium tolerance characterized by an accelerated rate of excretion of an administered load. Pitressin reverses this abnormality in sodium tolerance during the period corresponding to the delayed depressor phase of the response to the extract.
A WIDE VARIETY of evidence from many sources has tended to link an . abnormality of sodium metabolism to hypertensive disease both in man and in experimental animals. Although most studies have centered on the role of sodium, this has been in some measure fortuitous for it is evident that changes in sodium handling must, of necessity, entail shifts in water, in potassium, and probably in other electrolytes as well. Accordingly, it seems safer for the present to regard demonstrations of distortion in sodium balance only as representative of some basic abnormality in salt and water balance.
Recently we have presented preliminary evidence indicating that in those instances of experimental hypertension which show no overt sodium imbalance, a new equilibrium may have been established. 1 Under these circumstances, the imposition of a load may be followed by an excretory pattern which unmasks the underlying defect. In this study we emphasized the importance of studying the shape of the curve of excretion as is done in the case of other "tolerance" tests, rather than the total amount excreted. By this technique we demonstrated a common pattern of distortion in the excretory response to a "sodium tolerance test" in DCA hypertension, hypertension produced by renal compression and hypertension produced by Compound F. Elsewhere, we have demonstrated a similar pattern in hypertension produced by 9a-chlorohydroFrom the Department of Anatomy, The University of British Columbia, Vancouver, Canada.
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Received for publication April 21, 1955. cortisone 2 and most recently in spontaneous hypertension in aged rats (unpublished). The degree of change is not necessarily related to the degree of blood pressure elevation but the alteration is clearly of the same type in all of these divergent forms of experimental hypertension.
Parallel with these studies, we have been exploring the depressor effect of a large dose of Pitressin in the rat. Two types of depressor effect have now been distinguished.' The first, a "cumulative depressor response" occurs in all forms of experimental hypertension so far studied and is characterized by a progressive lowering of the basal morning blood pressure with continuing daily injections. The second, or "delayed depressor response" occurs only in DCA or Compound F induced hypertension (of the forms so far studied) and is characterized by a sustained depression of the blood pressure beginning three to five hours after Pitressin injection and lasting to the 9th post-injection hour. Evidence is being accumulated which suggests that the depressor principle may be separate from the pressor agent in Pitressin. 4 In view of the fact that Pitressin, under certain circumstances and in some species, may cause sodium loss 6 and in view of the sodium abnormality demonstrated in experimental hypertension, it seemed important to determine the effect of Pitressin on the "sodium tolerance" curve. As before, we selected hypertension produced by DCA, Compound F and renal compression as representative of different forms of experimental hypertension. The Pitressin dosage was selected as known to produce well marked "cumulative" and "de-layed" depressor effects. The sodium test load was administered so as to cover the period of known maximal blood pressure depression.
In these initial experiments Pitressin was found to reverse the distored "sodium tolerance" curve back to or beyond the normal; this is unexpected since it indicates sodium retention rather than sodium loss during the period of maximal blood pressure lowering.
METHODS
Adult male albino rats of an inbred Wistar strain were used throughout. Hypeitension was produced by renal compression, by the administration of DCA (desoxycorticosterone acetate) or Compound F acetate (hydrocortone acetate) as detailed for each experiment. Sodium tolerance was studied, as preiously described, by the administration of a standard load of 100 nig. NaCl in 3 cc. of water by gavage. 1 Following gavage, the rats were placed in metabolism funnels and urine was collected hourly for 5 periods, beginning one-half hour and ending four and one-half houre after the administration of the test Joad. In an attempt to determine the plasma sodium level at a uniform time without affecting the excretion response, 0.75 cc. of blood was withdrawn by cardiac puncture within one minute of of the final urine collection. Urine volume was measured at all periods except the last in the experiments dealing with hypertension produced by renal compi-ession and by Compound F. In the experiment dealing with DCA hypertension the terminal cardiac puncture was omitted in favor of securing accurate urine collections at all five periods.
Blood pressure was measured by direct cannulation of a femoral artery, under light ether anesthesia, with a 22 gage needle coupled through a Sanborn electromanometer to a direct writing recorder. In each experiment a starting blood pressure was measured two days prior to the administration of Pitressin and 10 days prior to the imposition of the salt loading procedure.
Pitressin (Parke-Davis) was given subcutaneously to the appropriate group in each experiment. In each case the dose was 2 I.U. in 0.5 cc. of saline daily for 8 injections. This dose was selected as the one which we have found to elicit clear cut depressor effects. Sodium tolerance was measured in the four and one-half hours beginning 3 hours after the last injection, a period cori'esponding to the time of maximal blood pressure lowering by Pitressin.
Urine and blood samples were analyzed for sodium, after appropriate dilution, using a Beckman Model B flame photometer. Standard error was cal--. The statistical culated from the formula n(n -1) analysis of differences between means followed Fisher's procedures and tables.' EXPERIMENTAL Experiment 1. The effect of £ I.U. of Pitressin on the response of rats uith lenal hypertension to tlie standard salt load test. This experiment used 27 male rats of an average weight of 2S1 grams. Of these, group 1 consisted of eight animals which had served from the start of the preparatory phase of the experiment as uninephrectomized controls. The remaining 19 had been subjected to the Grollman procedure for producing hypertension by renal compression 7 some two months prior to the present experiment. On the basis of a direct femoral artery determination, these 19 rats were selected as frankly hypertensive from a larger pool of rats subjected to renal compression.
The 19 rats with established renal hypertension were subdivided to form groups 2 and 3. Group 2, consisting of 10 animals, received no further treatment while group 3, consisting of 9 animals, received daily subcutaneous injections of 2 I.U. of Pitressin for S days. Thi'ee hours after the last injection a salt load test was carried out in all groups.
The findings are presented in table 1 and, in part, in figure 1. As described, blood pressure was well and equally elevated in both group 2 and group 3 prior to treatment with Pitressin. Urine volume over the period of loading was similar in both the normotensive and untreated hypertensive group. It was significantly reduced in the group receiving Pitressin. The pattern of sodium excretion in the hypertensive group was as described previously, that is, an acceleration in the rate of excretion of the administered sodium occurred. As we have shown, it is this change in rate which is constant, although it need not necessarily be accompanied by an increase in total amount. By contrast, the Pitressin treated hypertensive group 3 showed a marked decline in both the rate and total amount of sodium excreted. Plasma levels of sodium were the same in all groups at the end of loading despite the obvious retention of this ion in group 3.
Experiment S. The effect of S I.U. of Pitressin on the response of rats wiiJi DCA hypertension to the standard salt load test.
This experiment used 24 male rats of an average weight of 305 Gm. Of these, group 1 consisted of S animals which had served from the start of the preparatory phase of the experiment as uninephrectomized controls. The remaining 16 had been subjected to DCA treatment following unilateral nephrectomy. DCA was given by the implantation of one 25 ing. pellet followed after five weeks by the injection of 10 mg. of a microcrystalline suspension once weekly for 3 injections. The standard loading test was carried out 4 492 EFFECT OF PITRESSIN ON SODIUM TOLERANCE weeks after the cessation of all active treatment, although the animals were undoubtedly still absorbing small amounts of the steroid. These 16 rats were selected as frankly hj'pertensive from a larger pool of DCA treated rats. Selection was based on a preliminary direct femoral artery recording.
The 16 hypertensive rats were subdivided to form groups 2 and 3. Group 2 received no further treatment while group 3 received 2 I.U. of Pitressin subcutaneously for eight daily injections. Three hours after the last injection a salt load test was carried out in all groups. The findings are presented in table 2 and, in part, in figure 2.
As described, blood pressure was markedly and equally elevated in both groups 2 and 3 prior to treatment with Pitressin. Urine volume in response to load was markedly increased in the DCA treated group 2, but reduced to normal levels in the Pitressin treated group 3. Sodium excretion showed the characteristic acceleration in the rate as well as a moderate increase in total amount eliminated in group 2. (As presented, the data for this group show a wide standard error due to extremely low levels of sodium excretion in one animal.) Group 3, receiving Pitressin, showed marked sodium retention.
Experiment S. The effect of 8 I.U. of Pitressin on the response of rats wiUi Compound F hypertension to the standard saU load test.
This experiment used 21 male rats of an average weight of 192 grams. Of these, group 1 consisted of 7 untreated control animals. The remaining 14 animals of this series were selected as frankly hypertensive from a larger pool of rats subjected to treatment with Compound F acetate for 31 days prior to the start of the experi- FIQ. 2. The effect of Pitressin (2 I.U./day for 8 days subcutaneously) on the Na excretion pattern following gavage with 3 cc. of water containing 100 mg. NaCl in rats made hypertensive by DCA. The loading test was applied 3 hours after the last Pitressin injection. ment. The steroid was administered by daily injection of Hydrocortone acetate (Merck), 0.75 mg. on the fii'st day, 1.5 mg. on the second day and 3.0 mg. per day for the succeeding 29 days. As expected, this amount of Compound F caused some interference with growth. The dose schedule was based on our previous observations with this material. The administration of steroid was continued on a reduced basis (3.0 mg. every two days) for the 10 day experimental period following the blood pressure determination.
The 14 animals with established Compound F induced hypertension were subdivided to form groups 2 and 3. Group 2, consisting of 6 animals, received no treatment other than the steroid, while group 3, consisting of eight animals, received daily subcutaneous injections of 2 I.U. of Pitressin for eight days. Three hours after the last injection a salt load test was carried out in all groups. The findings are presented in table 3 and, in part, in figure 3.
As described, blood pressure was moderately elevated in both groups 2 and 3 prior to treatment with Pitressin. Urine volume in response to load was markedly increased in the Compound F treated group 2, but reduced back towards normal levels by treatment with Pitressin in group 3. Sodium excretion showed the characteristic acceleration in rate as well as a marked increase in total amount eliminated in group 2, while the excretory pattern in the Pitressin treated group 3 was essentially normal in type.
Plasma Na level was low at the end of the loading procedure in group 2, possibly reflecting 
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Fio. 3. The effect of Pitressin (2 I.U./day for S days subcutaneously) on the Na excretion pattern following gavage with 3 cc. of water containing 100 mg. NaCl in rats made hypertensive by Compound F. The loading test was applied 3 hours after the last Pitressin injection.
the marked Na loss in this group. It was normal in the Pitressin treated group 3.
DISCUSSION
The experiments here reported confirm our previous findings that an abnormality in the equilibrating mechanisms for sodium exists in hypertensive rate 1 . This imbalance may be masked by the presence of a new equilibrium so that some form of loading is required to reveal its presence. In certain forms of experimental hypertension in the rat, notably those produced by DCA or Compound F, the disturbance is so marked that the imposition of a sodium load may lead to an increase in the total sodium output as well as an acceleration in the rate of excretion. In other forms, notably those produced by renal compression, by 9a-chlorohydrocortisone and as a spontaneous phenomenon in age, the disturbance seems to be less intense so that the imposition of the load maj' not be followed by any manifest increase in the total sodium output, although there is an increased rate of excretion. The well defined acceleration in the rate of sodium output is thus a disturbance in pattern common to all forms of hypertension so far studied.
In our previous study we raised the question of whether the metabolic disturbance is prerenal, so that the kidney is involved only as a compensatory regulator, or primarily in the kidney itself. The fact that the abnormality may be completely reversed by Pitressin, an extract with definite renal effects, suggests that there can be little fundamentally the matter with a kidney which, under an appriate stimulus, is quite capable of retaining sodium under load.
The experiments reported here show quite clearly that Pitressin in adequate dosage reverses the accelerated pattern of sodium excretion under load in hypertensive rats. This means that during the depressor phase of Pitressin action, active sodium retention is the order rather than, as might have been expected, sodium loss. It should be noted that the period studied here, that is, three to seven and one-half hours after the injection of 2 I.U. of Pitressin, was chosen to correspond with the period of known maximal blood pressure depression. Others have reported 6 that an accelerated sodium loss occurs in the initial hours following Pitressin and experiments of ours not yet reported confirm this. Apparently then, Pitressin has a biphasic action on the renal handling of sodium as it does on the blood pressure, that is, an initial sodium-losing effect followed by a sodium-retaining one. This suggests for active study the possibility that the kidney is acting entirely as a homeostatic regulator.
These experiments on the whole indicate the need for a complete re-investigation of the effects of Pitressin on the renal regulation of salt metabolism. As Selkurt 5 has indicated, this field is at present confused; it may be so because of a failure to appreciate the importance of time intervals and the attendant necessity for prolonged periods of study coupled with estimations of renal function by clearance tests.
SUMMARY
A standard salt load test of 100 mg. NaCl in 3 cc. of water given by gavage was again used in the rat to explore mechanisms of sodium homeostasis in experimental hypertension. Three forms of experimental hypertension were studied to represent renal and hormonal mechanisms. Renal hypertension was produced by renal compression, hormonal hypertension by either DCA or Compound F.
Evidence was again obtained to show that animals subjected to hypertension inducing procedures develop an abnormal sodium tolerance, characterized by an accelerated rate of sodium elimination with or without an increase in the total amount excreted.
Pitressin administered subcutaneously in doses sufficient to produce a blood pressure lowering response reverses this abnormality in sodium tolerance during the period of maximal depression.
